Show simple item record

dc.contributor.authorBerners-Price, Sueen_US
dc.date.accessioned2017-04-04T15:22:48Z
dc.date.available2017-04-04T15:22:48Z
dc.date.issued2011en_US
dc.date.modified2012-02-13T05:01:50Z
dc.identifier.issn1433-7851en_US
dc.identifier.doi10.1002/anie.201004552en_US
dc.identifier.urihttp://hdl.handle.net/10072/42441
dc.description.abstractThe next generation: Classical PtII anticancer compounds contain cis diam(m)ine ligands and are activated by ligand-substitution reactions. PtIV diam(m)ine diazido dihydroxo complexes are nontoxic to cells until activated by light. Replacement of the diam(m)ine ligands in a trans configuration by pyridine gives a complex that is potently cytotoxic when irradiated with visible light and which has potential as a photochemotherapeutic agent.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_US
dc.languageGermanen_US
dc.publisherWiley - V C H Verlag GmbH & Co. KGaAen_US
dc.publisher.placeGermanyen_US
dc.relation.ispartofstudentpublicationNen_US
dc.relation.ispartofpagefrom804en_US
dc.relation.ispartofpageto805en_US
dc.relation.ispartofissue4en_US
dc.relation.ispartofjournalAngewandte Chemie International Editionen_US
dc.relation.ispartofvolume50en_US
dc.rights.retentionYen_US
dc.subject.fieldofresearchBioinorganic Chemistryen_US
dc.subject.fieldofresearchcode030201en_US
dc.titleActivating Platinum Anticancer Complexes with Visible Lighten_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.facultyOffice of the Snr Dep Vice Chancellor, Institute for Glycomicsen_US
gro.date.issued2011
gro.hasfulltextNo Full Text


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record